Nipro Corporation, together with its subsidiaries, engages in the medical equipment, pharmaceuticals, and glass businesses in Japan, the United States, Europe, and rest of Asia. The company’s Medical-Related Business segment offers injection and infusion products, artificial organ products, functional products, dialysis products, and diabetic products, as well as renal, intervention and anesthesiology, cardiopulmonary, and pharmaceutical kit products. Its Pharmaceutical-Related Business segment provides injectable drugs, including injection kits, etc.; oral drugs, such as orally-disintegrating tablets, etc.; generic anti-cancer drugs and biosimilars; and drugs for external use. The company’s Glass-Related Business segment offers tube glass for pharmaceuticals, vials, and ampoules; and glass material products for thermos bottles and lighting. Nipro Corporation is also involved in the rental of real estate properties. The company was founded in 1954 and is headquartered in Osaka, Japan.
nipro corp (8086:Tokyo Stock Exchange)
Phone: 81 6 6372 2331
Fax: 81 6 6375 0669www.nipro.co.jp
|Dr Reddy's Laboratories Ltd||3,643 INR||0.00|
|Fuso Pharmaceutical Industries Ltd||¥298.00 JPY||+1.00|
|JMS Co Ltd||¥296.00 JPY||0.00|
|Nikkiso Co Ltd||¥1,163 JPY||-6.00|
|NxStage Medical Inc||$16.67 USD||-0.14|
|View Industry Companies|
Sponsored Financial Commentaries
To contact NIPRO CORP, please visit www.nipro.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.